Agios Pharmaceuticals reported $-91806000 in Pre-Tax Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
Alnylam Pharmaceuticals ALNY:US $ -274.67M 35.32M
Arrowhead Research ARWR:US $ -72.05M 116.41M
Astellas Pharma 4503:JP Y 31679M 42195M
Biogen BIIB:US $ 874.8M 28.6M
Biomarin Pharmaceutical BMRN:US $ 34.85M 8.66M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Daiichi Sankyo 4568:JP Y 29415M 81785M
Epizyme EPZM:US $ -55.47M 4.84M
Exelixis EXEL:US $ 85.23M 32.79M
Immunogen IMGN:US $ -62.02M 37.88M
IONIS PHARMACEUT IONS:US $ -64M 289M
Mirati Therapeutics MRTX:US $ -176.44M 11.94M
Nektar Therapeutics NKTR:US $ -158.97M 68.7M
Novartis NOVN:VX SF 4129M 217M
Novartis NVS:US $ 4129M 217M
Sarepta Therapeutics SRPT:US $ -228.09M 123.95M